Galderma gava a priot notice to adopt a gel-type facial flushing treatment in the Korean market

Published: 2015-06-01 09:38:54

Updated: 2015-06-01 09:38:54

A spreading-type facial flushing treatment is expected to be adopted in the Korean market.

According to the industry concerned on the 29^th, Galderma has been working on a procedure to acquire a domestic approval of its self-developed gel-type facial flushing treatment with the ‘brimonidine’ substance, ‘Mirvaso.’

Its official launching period is expected to be in the first half of the next yea...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.